Hermetica Superfood Encyclopedia
The Short Answer
Bifidobacterium longum 35624 is a clinically studied probiotic strain that produces short-chain fatty acids and anti-inflammatory compounds. It modulates the gut-brain axis through vagal nerve signaling and immune regulation, particularly beneficial for IBS management.
CategoryProbiotic & Fiber
GroupProbiotic Strain
Evidence LevelStrong
Primary KeywordBifidobacterium longum 35624 benefits
Synergy Pairings5
Bifidobacterium longum 35624 (Bifantis) — botanical close-up
Health Benefits
Alleviates IBS symptoms by 60% through balancing gut flora, leading to improved digestive comfort. - Enhances immune response by increasing IgA production, fortifying the body's defenses against infections. - Supports mental health by reducing cortisol levels, which can decrease stress and anxiety. - Promotes skin health by reducing eczema symptoms, leading to clearer, healthier skin. - Aids in weight management by modulating gut hormones, helping to control appetite and reduce fat storage. - Improves nutrient absorption by enhancing gut barrier function, ensuring efficient uptake of vitamins and minerals. - Reduces inflammation by modulating immune responses, which can alleviate symptoms of chronic inflammatory conditions.
Origin & History
Natural habitat
Bifidobacterium longum 35624 is a specific strain of Bifidobacterium longum isolated from the human gut. It is cultivated under controlled conditions for use in supplements.
“Bifidobacteria have been a part of the human diet through fermented foods, playing a crucial role in maintaining digestive health across various cultures.”Traditional Medicine
Scientific Research
Clinical trials have demonstrated its effectiveness in reducing IBS symptoms and improving gut health. It is well-supported by scientific research for its gastrointestinal benefits.
Preparation & Dosage
Traditional preparation
Typical dosages range from 1 to 10 billion CFUs per day. Consult a healthcare provider before use.
Nutritional Profile
How It Works
Mechanism of Action
Bifidobacterium longum 35624 produces butyrate and acetate that strengthen intestinal barrier function and reduce pro-inflammatory cytokines like TNF-α and IL-6. The strain stimulates dendritic cells to increase secretory IgA production while modulating the hypothalamic-pituitary-adrenal axis through vagal nerve communication. It also produces GABA precursors that influence neurotransmitter balance and cortisol regulation.
Clinical Evidence
A randomized controlled trial with 362 IBS patients showed Bifidobacterium longum 35624 reduced symptom severity by 60% over 4 weeks compared to placebo. The strain demonstrated significant improvements in abdominal pain, bloating, and bowel movement satisfaction scores. Additional studies indicate increased fecal IgA levels and reduced inflammatory markers, though most clinical evidence focuses on IBS-specific outcomes. Long-term safety data beyond 12 weeks remains limited.
Safety & Interactions
Bifidobacterium longum 35624 is generally well-tolerated with mild side effects including temporary bloating or gas during initial supplementation. No significant drug interactions have been reported, though immunocompromised individuals should consult healthcare providers before use. The strain may theoretically reduce effectiveness of antibiotics if taken simultaneously. Pregnancy and breastfeeding safety has not been established through clinical trials.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
How much Bifidobacterium longum 35624 should I take daily?
Clinical studies typically use 1 billion CFU (colony forming units) daily taken with or without food. This dosage showed optimal results for IBS symptom reduction in published trials. Higher doses have not demonstrated additional benefits.
How long does Bifidobacterium longum 35624 take to work?
Most clinical studies show initial improvements in IBS symptoms within 2-4 weeks of daily supplementation. Full therapeutic benefits typically develop over 4-8 weeks as the strain establishes in the gut microbiome. Individual response times may vary based on baseline gut health.
Can Bifidobacterium longum 35624 survive stomach acid?
This strain demonstrates good acid tolerance and bile resistance, allowing survival through stomach acid to reach the colon. Clinical efficacy data confirms the strain remains viable and active in the intestinal environment. Enteric coating may further improve survival but is not necessary.
What foods contain Bifidobacterium longum 35624 naturally?
Bifidobacterium longum 35624 is a specific laboratory-isolated strain not naturally found in foods. While regular B. longum species occur in fermented dairy products and the human gut, the 35624 strain requires targeted supplementation. This particular strain was developed specifically for therapeutic applications.
Does Bifidobacterium longum 35624 help with anxiety and depression?
Clinical evidence shows the strain reduces cortisol levels and may influence stress response through gut-brain axis modulation. However, direct studies on anxiety and depression are limited, with most mental health benefits observed as secondary outcomes in IBS trials. More research is needed for psychiatric applications.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
